175 related articles for article (PubMed ID: 31292912)
1. Reactive C cell hyperplasia as an incidental finding after thyroidectomy for papillary carcinoma.
Manatakis DK; Bakavos A; Soulou VN; Dimakis C; Tseleni-Balafouta S
Hormones (Athens); 2019 Sep; 18(3):289-295. PubMed ID: 31292912
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.
Wang SF; Zhao WH; Wang WB; Teng XD; Teng LS; Ma ZM
Asian Pac J Cancer Prev; 2013; 14(2):707-11. PubMed ID: 23621223
[TBL] [Abstract][Full Text] [Related]
3. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study.
Karatzas T; Charitoudis G; Vasileiadis D; Kapetanakis S; Vasileiadis I
Int J Surg; 2015 Jun; 18():64-8. PubMed ID: 25900600
[TBL] [Abstract][Full Text] [Related]
5. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
Perry A; Molberg K; Albores-Saavedra J
Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy?
Vasileiadis I; Boutzios G; Karalaki M; Misiakos E; Karatzas T
Am J Surg; 2018 Jul; 216(1):135-139. PubMed ID: 28954712
[TBL] [Abstract][Full Text] [Related]
8. Multifocality related factors in papillary thyroid carcinoma.
Gur EO; Karaisli S; Haciyanli S; Kamer E; Genc H; Atahan K; Haciyanli M
Asian J Surg; 2019 Jan; 42(1):297-302. PubMed ID: 30585170
[TBL] [Abstract][Full Text] [Related]
9. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
11. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
12. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
13. Benign and malignant thyroid nodules with autoimmune thyroiditis.
Kassi GN; Evangelopoulou CC; Papapostolou KD; Karga HJ
Arch Endocrinol Metab; 2022 Sept 08; 66(4):446-451. PubMed ID: 35657125
[TBL] [Abstract][Full Text] [Related]
14. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
15. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
16. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
17. Association between chronic lymphocytic thyroiditis and papillary thyroid carcinoma: A retrospective study in surgical specimens.
Osorio C; Ibarra S; Arrieta J; Sarmiento M; Barrios D; Sierra L; Redondo K; Francisco Herrera
Rev Esp Patol; 2020; 53(3):149-157. PubMed ID: 32650966
[TBL] [Abstract][Full Text] [Related]
18. Incidental thyroid C cell hyperplasia: clinical significance and implications in practice.
Sakorafas GH; Nasikas D; Thanos D; Gantzoulas S
Oncol Res Treat; 2015; 38(5):249-52. PubMed ID: 25966772
[TBL] [Abstract][Full Text] [Related]
19. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.
Dong S; Xia Q; Wu YJ
Otolaryngol Head Neck Surg; 2015 Jul; 153(1):20-6. PubMed ID: 25917667
[TBL] [Abstract][Full Text] [Related]
20. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]